RLAY – relay therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Relay Therapeutics, Inc. (NASDAQ: RLAY) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $15.00 price target on the stock.
VantAI Appoints John Cuozzo as Senior Vice President, Head of Drug Discovery [Yahoo! Finance]
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $24.00 price target on the stock.
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $25.00 price target on the stock, down previously from $33.00.
Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
Form 10-Q Relay Therapeutics, Inc. For: Mar 31
Form 8-K Relay Therapeutics, Inc. For: May 02
Form 4 Relay Therapeutics, Inc. For: Apr 29 Filed by: Rahmer Peter
Form 4 Relay Therapeutics, Inc. For: Apr 29 Filed by: Adams Brian
Form 4 Relay Therapeutics, Inc. For: Apr 29 Filed by: Catinazzo Thomas
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.